Increasing antibiotic resistance in clinical isolates of Aeromonas strains in Taiwan | Zendy

WenChien Ko | Zendy; Kai-Wei Yu | Zendy; CHENGYI LIU | Zendy; ChunKai Huang | Zendy; H S Leu | Zendy; Yin-Ching Chuang | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Increasing antibiotic resistance in clinical isolates of Aeromonas strains in Taiwan

Author(s) -

WenChien Ko,

Kai-Wei Yu,

CHENGYI LIU,

ChunKai Huang,

H S Leu,

Yin-Ching Chuang

Publication year - 1996

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.40.5.1260

Subject(s) - aztreonam , cefepime , microbiology and biotechnology , imipenem , aeromonas , amikacin , cephalosporin , ceftazidime , aeromonas hydrophila , trimethoprim , agar dilution , antibiotics , biology , cefotaxime , antibiotic resistance , minimum inhibitory concentration , bacteria , pseudomonas aeruginosa , genetics

A total of 234 clinical isolates of Aeromonas, primarily A. hydrophila, were collected for the present study. Most were isolates from blood. By the agar dilution method, more than 90% of the Aeromonas strains were found to be susceptible to moxalactam, ceftazidime, cefepime, aztreonam, imipenem, amikacin, and fluoroquinolones, but they were more resistant to tetracycline, trimethoprim-sulfamethoxazole, some extended-spectrum cephalosporins, and aminoglycosides than strains from the United States and Australia.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research